Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: A plea for multimodal immune modulating therapy in the respiratory insufficient patient

The FOLFOX regimen, ., folinic acid (FOL), fluorouracil (F) and oxaliplatin (OX), is a drug cocktail that is used to treat gastric and colorectal cancers. Despite the concomitant improvements in response rate, duration of response and patient survival, reports of serious toxic pulmonary side effects have progressively emerged. | Prognosis and treatment of FOLFOX therapy related interstitial pneumonia A plea for multimodal immune modulating therapy in the respiratory insufficient patient

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN